Skip to main content
Frontiers in Public Health logoLink to Frontiers in Public Health
. 2026 Sep 17;14:1949710. doi: 10.3389/fpubh.2026.1949710

Perioperative nutrition-oriented nursing for older women undergoing cancer surgery: frailty screening, enhanced recovery, and survivorship care

Yun Feng 1, Feng Yuan 2, Bingqing Kong 1,*
PMCID: PMC13628584  PMID: 42824555

Abstract

Older women undergoing cancer surgery commonly enter the perioperative period with overlapping frailty, malnutrition, sarcopenia, obesity, multimorbidity, and treatment-related symptoms. These vulnerabilities reduce physiologic reserve and amplify the catabolic response to surgery, increasing the risk of complications, functional decline, delayed adjuvant treatment, and persistent nutritional impairment. Nutrition-oriented perioperative nursing provides a practical framework for translating frailty assessment and cancer nutrition guidance into coordinated care before surgery, during enhanced recovery, and after discharge. This Mini Review examines the frailty-malnutrition-surgical stress axis in older women with breast, gynecologic, thoracic, and other cancers requiring surgery. We propose an integrated two-step approach in which brief frailty and nutrition screening triggers multidimensional assessment, dietitian referral, symptom management, protein-energy support, and multimodal pre-habilitation. Within enhanced recovery pathways, nurses can protect nutritional intake by limiting unnecessary fasting, supporting individualized carbohydrate use, preventing postoperative nausea and vomiting, promoting early protein-containing oral feeding, and coordinating early mobilization. Continued reassessment after discharge is required because muscle loss, appetite disturbance, and treatment-related nutritional problems may persist into adjuvant therapy and survivorship. Current evidence supports integrated screening and multimodal care, but women-specific trials in geriatric oncology remain limited. Future studies should evaluate nurse-led implementation using functional, nutritional, treatment-continuity, and patient-reported outcomes rather than length of stay alone.

Keywords: enhanced recovery after surgery, frailty, older women with cancer, oncology nursing, perioperative nutrition, prehabilitation, sarcopenia, survivorship

1. Introduction

Cancer surgery is increasingly performed in older women, including those with breast, endometrial, ovarian, cervical, vulvar, lung, and gastrointestinal malignancies. Chronologic age alone does not determine surgical resilience. Frailty, malnutrition, sarcopenia, multimorbidity, obesity, polypharmacy, cognitive vulnerability, and social support collectively shape the ability to tolerate surgery and recover function (1–7). In women, menopause-related changes in body composition and bone health may coexist with obesity or sarcopenic obesity, making low muscle reserve difficult to recognize from body mass index alone.

Nutrition is a modifiable component of this vulnerability. Cancer-related inflammation, reduced intake, gastrointestinal symptoms, depression, pain, and preoperative treatment can accelerate muscle loss. Malnutrition defined by the Global Leadership Initiative on Malnutrition (GLIM) criteria is associated with poorer survival and more postoperative complications in cancer populations, while frailty independently predicts mortality, complications, prolonged hospitalization, and non-home discharge after cancer surgery (8–13). In gynecologic oncology, malnutrition and sarcopenia are common and are associated with adverse postoperative or survival outcomes (14–19).

A tailored focus on older women is warranted because postmenopausal endocrine and body-composition changes can reduce muscle and bone reserve while increasing the likelihood of sarcopenic obesity that is not apparent from body mass index alone. Women-specific cancer surgery and treatment sequelae may coexist with widowhood, living alone, caregiving obligations, and restricted access to food preparation, transportation, or rehabilitation. These intersecting biological and social vulnerabilities are not consistently represented in mixed-sex perioperative studies and support a sex and gender-responsive nursing pathway (10, 18, 20).

Perioperative nurses are positioned at the interface of assessment, surgical preparation, anesthesia, symptom control, early feeding, mobilization, discharge education, and continuity of care. A nutrition-oriented nursing model does not replace dietitians, geriatricians, anesthesiologists, surgeons, or rehabilitation professionals. Its role is to ensure that nutritional and functional vulnerability is recognized early, translated into an actionable pathway, and monitored across transitions. This Mini Review integrates frailty screening, nutritional optimization, enhanced recovery after surgery (ERAS), and survivorship-oriented follow-up for older women undergoing cancer surgery.

2. Why older women are nutritionally vulnerable before cancer surgery

Older women with cancer frequently present with mixed nutritional phenotypes. Some have visible weight loss and low body mass, whereas others have obesity with depleted muscle quantity or quality. Prospective and meta-analytic evidence in gynecologic cancer demonstrates that sarcopenia may be present despite normal or elevated body mass index and is associated with worse survival (15–17). In women aged 80 years or older with gynecologic malignancy, frailty and comorbidity have stronger relationships with treatment tolerance and survival than age alone (18).

The preoperative period can intensify these risks. Diagnostic procedures, neoadjuvant therapy, pain, nausea, early satiety, constipation, anxiety, and restrictions imposed by patients or caregivers may reduce energy and protein intake. Inflammatory signaling and insulin resistance promote anabolic resistance, while inactivity accelerates loss of muscle strength. Albumin is influenced by inflammation and should not be used as a stand-alone nutritional diagnosis, but low albumin and weight loss remain clinically useful warning signals when interpreted with intake, phenotype, and disease burden. A systematic two-step process—rapid screening followed by multidimensional assessment—is therefore preferable to isolated laboratory testing (7–10).

Nutrition vulnerability also has a gendered and social dimension. Older women may live alone, depend on caregivers for shopping and food preparation, or prioritize family responsibilities over their own intake. Financial constraints and transportation barriers may limit access to oral nutritional supplements, dietitians, or pre-habilitation. Nursing assessment should therefore include food access, oral health, swallowing, gastrointestinal symptoms, cultural food practices, health literacy, and the feasibility of implementing recommendations at home.

3. Integrated frailty and nutrition screening as a nursing pathway

Screening should occur when surgery is first planned, not on the evening before the procedure. A brief frailty tool such as the Clinical Frailty Scale or FRAIL scale can be paired with a validated nutrition screen such as NRS-2002, the Malnutrition Screening Tool, or the abridged Patient-Generated Subjective Global Assessment. Frailty identified by simple scales is associated with postoperative complications, delirium, and mortality, but no single instrument captures all relevant domains (11–13). Positive screening should trigger comprehensive geriatric and nutritional assessment rather than function as a reason to deny surgery.

The second step should characterize potentially reversible deficits. Relevant components include recent weight change, usual intake, symptom burden, muscle strength, mobility, cognition, mood, comorbidity, medication burden, social support, and the planned surgical stress. GLIM diagnosis requires at least one phenotypic and one etiologic criterion (8). Handgrip strength, chair-stand performance, gait speed, or calf circumference can complement the assessment. When preoperative computed tomography is already available, opportunistic assessment of skeletal muscle may identify sarcopenia or myosteatosis, but imaging should not delay care.

Nurses can operationalize risk stratification using the practical pathway summarized in Table 1. Low risk indicates negative frailty and nutrition screens with stable intake and function; moderate risk indicates a positive screen or a potentially reversible decline; and high risk indicates established malnutrition, frailty, marked intake reduction, sarcopenia, or major functional dependence. Each level should trigger a predefined referral and follow-up plan rather than serve as a reason to deny surgery.

Table 1.

Practical frailty-nutrition risk stratification and nursing response.

Risk level Screening tools and positive findings Referral or escalation Priority nursing actions
Low CFS 1–3 or FRAIL 0; NRS-2002 < 3 and MST < 2; stable weight, intake, mobility, and cognition Routine perioperative pathway; repeat screening if clinical status changes Standard ERAS education; reconcile fasting and feeding instructions; monitor intake, symptoms, and mobility
Moderate CFS 4 or FRAIL 1–2; NRS-2002 ≥ 3 or MST ≥ 2; recent weight, intake, strength, or mobility decline Dietitian and physiotherapy referral; consider geriatric or medical review Symptom-directed counseling; protein-energy support; home-based pre-habilitation; scheduled preoperative reassessment
High CFS ≥ 5 or FRAIL ≥3; GLIM-defined malnutrition, marked intake reduction, sarcopenia, or major functional/cognitive dependence Multidisciplinary review involving nutrition, geriatrics, anesthesia, surgery, and rehabilitation; consider optimization before surgery when oncologically safe Individualized nutrition and pre-habilitation plan; early postoperative feeding and mobilization; documented discharge plan and early post-discharge follow-up

Thresholds are pragmatic examples based on commonly used tools (7, 8, 10–13). Positive screens should prompt multidimensional assessment and do not independently define malnutrition or preclude surgery. CFS, Clinical Frailty Scale; ERAS, enhanced recovery after surgery; FRAIL, Fatigue, Resistance, Ambulation, Illnesses, and Loss of weight; GLIM, Global Leadership Initiative on Malnutrition; MST, Malnutrition Screening Tool; NRS-2002, Nutritional Risk Screening 2002.

4. The frailty-malnutrition-surgical stress axis

Frailty and malnutrition interact with the surgical stress response through a common metabolic pathway. Aging, cancer inflammation, endocrine change, low intake, and inactivity reduce muscle reserve and anabolic responsiveness. Surgical trauma then activates sympathetic and hypothalamic–pituitary–adrenal pathways, releasing catecholamines and cortisol and increasing inflammatory mediators such as IL-6, TNF-alpha, and C-reactive protein. Hyperglycemia, pain, fasting, nausea, and immobility further increase insulin resistance and suppress intake (21).

In a patient with adequate reserve, this response is usually reversible. In a frail older woman, the same stress may cross a functional threshold. Proteolytic pathways and dysregulated autophagy accelerate muscle breakdown, while mitochondrial dysfunction limits energy production. Reduced protein availability impairs wound healing and immune competence; prolonged fasting and opioid-related gastrointestinal dysfunction delay feeding; and postoperative inactivity reinforces muscle loss. Immediate postoperative muscle loss has been associated with inadequate protein and energy intake (22).

This axis provides a mechanistic rationale for coordinated nursing interventions (Figure 1). Prehabilitation increases reserve before surgery; ERAS reduces avoidable stress during the perioperative period; early protein-containing nutrition and mobilization limit postoperative catabolism; and longitudinal monitoring prevents short-term deterioration from becoming chronic disability. The intervention target is therefore not a single nutrient but the interaction among intake, muscle, inflammation, symptoms, and function.

Figure 1.

Flow chart illustration showing how pre-existing risk factors such as aging, cancer inflammation, endocrine change, low intake, and inactivity lead to reduced muscle reserve and anabolic responsiveness, which, in combination with surgical insult and perioperative modifiers, contribute to increased inflammatory mediators, exacerbated insulin resistance, suppressed intake, and ultimately impaired recovery and outcomes.

Frailty-malnutrition-surgical stress axis and interruption points for perioperative nutrition-oriented nursing in older women undergoing cancer surgery. Aging, cancer-related inflammation, endocrine change, reduced intake, comorbidity, and inactivity reduce muscle and physiologic reserve. Surgical trauma amplifies cortisol and catecholamine release, inflammatory signaling, insulin resistance, fasting, nausea, and immobility, promoting muscle proteolysis, autophagy imbalance, mitochondrial dysfunction, and impaired immune, wound, and gastrointestinal recovery. Nutrition-oriented nursing interrupts this pathway through integrated frailty and nutrition screening, protein-energy support, multimodal prehabilitation, reduction of unnecessary fasting, symptom control, early protein-containing oral nutrition, mobilization, and longitudinal reassessment.

5. Nutrition-oriented nursing within enhanced recovery

Preoperative phase. Education should explain why nutrition and activity are part of surgical treatment. Nurses should reconcile conflicting fasting instructions, identify nausea, constipation, dysphagia, pain, or anxiety that limits intake, and verify that referred women can access dietetic care. Current pre-habilitation evidence suggests that exercise and nutritional support are important components, although certainty varies and frail cancer populations remain underrepresented (23–26). A recent multimodal program in women with gynecologic cancer improved physical fitness and reduced the proportion at moderate or high risk of malnutrition before surgery (27). For women with inadequate intake, oral nutritional supplements or food-based protein-energy enrichment may be used under dietetic guidance.

Immediate perioperative phase. The operating-room and anesthesia nursing team can protect recovery by implementing ERAS elements consistently: avoiding unnecessary prolonged fasting, confirming individualized use of preoperative carbohydrate drinks when appropriate, maintaining normothermia and euvolemia, supporting glycemic control, and enabling opioid-sparing analgesia. Prevention of postoperative nausea and vomiting is a nutrition intervention because uncontrolled symptoms delay drinking and eating. ERAS programs in gynecologic surgery reduce length of stay, readmission, and ileus without evidence of harm, and can be implemented in women with obesity or major procedures when supported by experienced teams (28–30).

Postoperative phase. Oral intake should resume as early as clinically feasible rather than waiting routinely for bowel sounds or flatus. Immunonutrition may reduce infectious complications in selected upper gastrointestinal cancer surgery, but evidence is not sufficiently women-specific to support indiscriminate use (31). Meta-analyses support early oral feeding after gastrointestinal surgery, and protein-containing diets may be more clinically relevant than non-nutritive clear fluids (32, 33). Early enteral feeding after pelvic exenteration has also been shown to be feasible and beneficial for gastrointestinal recovery (34). Nurses should assess swallowing, nausea, pain, ileus, diarrhea, early satiety, and food acceptability; document actual intake rather than diet orders alone; and escalate persistent deficits promptly.

Early mobilization must be coordinated with nutrition. Feeding without muscle loading may not restore function, while exercise without adequate intake may deepen energy deficit. For older women with cancer who are malnourished, sarcopenic, or unable to meet needs through usual intake, approximately 1.2 g/kg/day may be considered a contextual lower target rather than a universal prescription (35). The selected target and body-weight metric should be individualized by the dietitian or clinical nutrition team according to renal function, cancer type, disease burden, obesity or edema, treatment plan, and physical activity. Immediate postoperative muscle loss has also been associated with inadequate protein and energy intake, reinforcing the need to document actual intake and coordinate nutrition with muscle loading (22).

Breast-cancer perioperative nursing literature emphasizes structured education, symptom control, functional support, and continuity across the surgical pathway (36). Patient-experience evidence also indicates that inconsistent information, limited communication, and poor acceptability of postoperative diets can reduce engagement with ERAS and nutrition pathways; nursing messages and diet progression should therefore be consistent, individualized, and reinforced across transitions (37, 38).

6. From discharge to survivorship care

Discharge is not the end of perioperative nutrition care. Older women may experience appetite loss, altered taste, constipation, diarrhea, fatigue, wound problems, or practical difficulty preparing food after returning home. Some cancer operations create durable changes in digestion or absorption, and postoperative muscle loss can persist well beyond hospital discharge (39). The transition is particularly vulnerable when adjuvant chemotherapy or radiotherapy begins before nutritional recovery is complete.

A survivorship-oriented pathway should specify who reassesses weight, intake, muscle function, and frailty; when escalation occurs; and how information moves between surgical oncology, primary care, community nursing, rehabilitation, and dietetics. Individualized dietary counseling after cancer surgery can improve energy and protein goal attainment, reduce weight loss, and improve quality-of-life domains (40). Evidence from women aged 80 years or older with endometrial cancer further supports incorporating comorbidity and functional status into follow-up planning rather than relying on chronological age alone (41). Telephone or digital follow-up may support symptom monitoring, but should not replace face-to-face assessment for women with cognitive, sensory, or digital-access barriers.

Nursing outcomes should extend beyond length of stay. Relevant measures include nutritional risk, handgrip strength, chair-stand performance, mobility, and treatment completion, time to adjuvant therapy, readmission, patient confidence, caregiver burden, and quality of life. Older female cancer survivors with stress, depression, comorbidity, and low positive affect may have greater frailty, underscoring the need to integrate psychosocial support with nutrition and function (20). Perioperative nursing research should therefore treat survivorship as a continuation of recovery rather than a separate phase.

7. Implementation priorities and evidence gaps

The evidence base has three important limitations. First, many perioperative nutrition and pre-habilitation trials combine cancer sites and include relatively few older women. Findings from colorectal or upper gastrointestinal surgery cannot be transferred uncritically to breast and gynecologic oncology. Second, screening tools and sarcopenia definitions vary, limiting comparison and implementation. Third, intervention studies often measure short-term complications and length of stay but not muscle preservation, independence, adjuvant-treatment continuity, or long-term quality of life.

Future trials should recruit risk-enriched groups, including women aged 70 years or older, those with ovarian or endometrial cancer, obesity with low muscle mass, prior neoadjuvant treatment, and limited social support. Interventions should report the exact nutritional dose, exercise prescription, symptom-management strategy, and nursing contact time. Pragmatic studies should compare a clearly defined nurse-coordinated pathway with usual care and include implementation outcomes such as screening completion, referral uptake, time to intervention, fidelity, equity, and cost.

Clinical implementation can begin before definitive women-specific trials are complete. Institutions can standardize a two-step frailty-nutrition screen, create automatic referral thresholds, align fasting and feeding instructions across disciplines, monitor actual postoperative intake, and schedule reassessment after discharge. These actions are consistent with current geriatric oncology, cancer nutrition, and surgical nutrition guidance (3–5, 7). Experience in obese gynecologic oncology populations also suggests that ERAS pathways can be implemented when metabolic, anesthetic, nutritional, and mobility needs are individualized (42).

8. Conclusion

Older women undergoing cancer surgery face a convergent risk of frailty, malnutrition, sarcopenia, surgical stress, and incomplete recovery. Nutrition-oriented perioperative nursing converts this risk profile into an actionable continuum: integrated screening, pre-habilitation, reduced perioperative stress, early protein-containing feeding, mobilization, symptom control, and survivorship follow-up. The approach should be individualized, multidisciplinary, and evaluated by preservation of function and treatment continuity as well as conventional surgical outcomes. Women-specific geriatric oncology trials are needed, but routine nursing practice can already ensure that nutritional vulnerability is identified early and not lost at transitions of care.

Funding Statement

The author(s) declared that financial support was not received for this work and/or its publication.

Footnotes

Edited by: Wangshu Li, Women and Children's Hospital Affiliated to Dalian University of Technology, China

Reviewed by: Shengnan Wang, The Second Affiliated Hospital of Fujian Medical University, China

Author contributions

YF: Writing – original draft, Writing – review & editing, Conceptualization, Formal analysis. FY: Writing – original draft, Writing – review & editing. BK: Writing – original draft, Writing – review & editing, Conceptualization, Formal analysis.

Conflict of interest

The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Generative AI statement

The author(s) declared that Generative AI was not used in the creation of this manuscript.

Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

  • 1.Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. (2024) 74:229–63. doi: 10.3322/caac.21834, [DOI] [PubMed] [Google Scholar]
  • 2.Rock CL, Thomson CA, Sullivan KR, Howe CL, Kushi LH, Caan BJ, et al. American Cancer Society nutrition and physical activity guideline for cancer survivors. CA Cancer J Clin. (2022) 72:230–62. doi: 10.3322/caac.21719, [DOI] [PubMed] [Google Scholar]
  • 3.Muscaritoli M, Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, et al. ESPEN practical guideline: clinical nutrition in cancer. Clin Nutr. (2021) 40:2898–913. doi: 10.1016/j.clnu.2021.02.005 [DOI] [PubMed] [Google Scholar]
  • 4.Weimann A, Bezmarevic M, Braga M, Correia MITD, Funk-Debleds P, Gianotti L, et al. ESPEN guideline on clinical nutrition in surgery—update 2025. Clin Nutr. (2025) 53:222–61. doi: 10.1016/j.clnu.2025.08.029, [DOI] [PubMed] [Google Scholar]
  • 5.Dale W, Klepin HD, Williams GR, Alibhai SMH, Bergerot C, BrintzenhofeSzoc K, et al. Practical assessment and management of vulnerabilities in older patients receiving systemic cancer therapy: ASCO guideline update. J Clin Oncol. (2023) 41:4293–312. doi: 10.1200/JCO.23.00933, [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Ligibel JA, Bohlke K, May AM, Clinton SK, Demark-Wahnefried W, Gilchrist SC, et al. Exercise, diet, and weight management during cancer treatment: ASCO guideline. J Clin Oncol. (2022) 40:2491–507. doi: 10.1200/JCO.22.00687, [DOI] [PubMed] [Google Scholar]
  • 7.Bauer JM, Pattwell M, Barazzoni R, Battisti NML, Soto-Perez-de-Celis E, Hamaker ME, et al. Systematic nutritional screening and assessment in older patients: rationale for its integration into oncology practice. Eur J Cancer. (2024) 209:114237. doi: 10.1016/j.ejca.2024.114237, [DOI] [PubMed] [Google Scholar]
  • 8.Cederholm T, Jensen GL, Correia MITD, Gonzalez MC, Fukushima R, Higashiguchi T, et al. GLIM criteria for the diagnosis of malnutrition: a consensus report. Clin Nutr. (2019) 38:1–9. doi: 10.1016/j.clnu.2018.08.002 [DOI] [PubMed] [Google Scholar]
  • 9.Matsui R, Rifu K, Watanabe J, Inaki N, Fukunaga T. Impact of malnutrition as defined by the GLIM criteria on treatment outcomes in patients with cancer: a systematic review and meta-analysis. Clin Nutr. (2023) 42:615–24. doi: 10.1016/j.clnu.2023.02.019, [DOI] [PubMed] [Google Scholar]
  • 10.Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. (2019) 48:16–31. doi: 10.1093/ageing/afy169, [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Shaw JF, Budiansky D, Sharif F, McIsaac DI. The association of frailty with outcomes after cancer surgery: a systematic review and meta-analysis. Ann Surg Oncol. (2022) 29:4690–704. doi: 10.1245/s10434-021-11321-2, [DOI] [PubMed] [Google Scholar]
  • 12.Engel JS, Tran J, Khalil N, Hladkowicz E, Lalu MM, Huang A, et al. A systematic review of perioperative clinical practice guidelines for care of older adults living with frailty. Br J Anaesth. (2023) 130:262–71. doi: 10.1016/j.bja.2022.12.010 [DOI] [PubMed] [Google Scholar]
  • 13.Gong S, Qian D, Riazi S, Chung F, Englesakis M, Li Q, et al. Association between the FRAIL scale and postoperative complications in older surgical patients: a systematic review and meta-analysis. Anesth Analg. (2023) 136:251–61. doi: 10.1213/ANE.0000000000006272, [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Goins EC, Weber JM, Truong T, Moss HA, Previs RA, Davidson BA, et al. Malnutrition as a risk factor for post-operative morbidity in gynecologic cancer: analysis using a national surgical outcomes database. Gynecol Oncol. (2022) 165:309–16. doi: 10.1016/j.ygyno.2022.01.030, [DOI] [PubMed] [Google Scholar]
  • 15.Yamada R, Todo Y, Minowa K, Minobe S, Suzuki Y, Kato H, et al. Prevalence of sarcopenia in patients with gynecological cancer. Jpn J Clin Oncol. (2022) 52:1001–7. doi: 10.1093/jjco/hyac087 [DOI] [PubMed] [Google Scholar]
  • 16.Lin WL, Nguyen THY, Lin CY, Wu LM, Huang WT, Guo HR. Association between sarcopenia and survival in patients with gynecologic cancer: a systematic review and meta-analysis. Front Oncol. (2022) 12:1037796. doi: 10.3389/fonc.2022.1037796, [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Jiang C, Chen Q, Yu D, Zhou Q, Tang C, Qiao C. Prevalence and prognostic significance of sarcopenia in gynecologic oncology: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. (2025) 16:e13699. doi: 10.1002/jcsm.13699 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Reiser E, Potsch N, Seebacher V, Reinthaller A, Wimazal F, Fleischmann E, et al. Impact of frailty on the management of patients with gynecological cancer aged 80 years and older. Arch Gynecol Obstet. (2021) 303:557–63. doi: 10.1007/s00404-020-05807-9, [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Levine MD, Felix AS, Meade CE, Bixel KL, Chambers LM. The modified 5-item frailty index is a predictor of post-operative complications in vulvar cancer: a National Surgical Quality Improvement Program analysis. Int J Gynecol Cancer. (2023) 33:465–72. doi: 10.1136/ijgc-2022-004175 [DOI] [PubMed] [Google Scholar]
  • 20.Rio CJ, Saligan LN, Li X, Crouch A, Von Ah D. Correlates of frailty in older female cancer survivors. J Geriatr Oncol. (2024) 15:101682. doi: 10.1016/j.jgo.2023.101682, [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Kelliher LJS, Scott M. Modifying the stress response—perioperative considerations and controversies. Anesthesiol Clin. (2022) 40:23–33. doi: 10.1016/j.anclin.2021.11.012, [DOI] [PubMed] [Google Scholar]
  • 22.Hardy EJ, Deane CS, Lund JN, Phillips BE. Loss of muscle mass in the immediate post-operative period is associated with inadequate dietary protein and energy intake. Eur J Clin Nutr. (2023) 77:503–5. doi: 10.1038/s41430-023-01264-0, [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Guo Y, Ding L, Miao X, Jiang X, Xu T, Xu X, et al. Effects of prehabilitation on postoperative outcomes in frail cancer patients undergoing elective surgery: a systematic review and meta-analysis. Support Care Cancer. (2023) 31:57. doi: 10.1007/s00520-022-07541-1, [DOI] [PubMed] [Google Scholar]
  • 24.Bai Z, Koh C, Solomon M, Shahab R, Hirst N, Alexander K, et al. Prehabilitation in frail patients undergoing cancer surgery: a systematic review and meta-analysis. Ann Surg Oncol. (2025) 32:7707–22. doi: 10.1245/s10434-025-17589-y, [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.McIsaac DI, Kidd G, Gillis C, Branje K, Al-Bayati M, Baxi A, et al. Relative efficacy of prehabilitation interventions and their components: systematic review with network and component network meta-analyses of randomised controlled trials. BMJ. (2025) 388:e081164. doi: 10.1136/bmj-2024-081164, [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.She KY, Huang L, Zhang HT, Gao Y, Yao KR, Luo Q, et al. Effect of prehabilitation on postoperative outcomes in the frail older people: a systematic review and meta-analysis. Geriatr Nurs. (2024) 55:79–88. doi: 10.1016/j.gerinurse.2023.10.027, [DOI] [PubMed] [Google Scholar]
  • 27.Dhanis J, Pijnenborg JMA, van Laarhoven CJHM, Verlaan S, van der Heuvel B, Smits A. The effect of a multimodal prehabilitation programme on preoperative physical fitness and nutritional status of women with gynaecological cancer. Gynecol Oncol. (2025) 203:1–7. doi: 10.1016/j.ygyno.2025.10.012, [DOI] [PubMed] [Google Scholar]
  • 28.O'Neill AM, Calpin GG, Norris L, Beirne JP. The impact of enhanced recovery after gynaecological surgery: a systematic review and meta-analysis. Gynecol Oncol. (2023) 168:8–16. doi: 10.1016/j.ygyno.2022.10.019, [DOI] [PubMed] [Google Scholar]
  • 29.Cao S, Zhang Y, Lin B, Chen J, Chen X, Zhuang C. Enhanced recovery after gynecological surgery: a meta-analysis of randomized controlled trials. Nurs Health Sci. (2023) 25:30–43. doi: 10.1111/nhs.13000, [DOI] [PubMed] [Google Scholar]
  • 30.Huepenbecker SP, Soliman PT, Meyer LA, Iniesta MD, Chisholm GB, Taylor JS, et al. Perioperative outcomes in gynecologic pelvic exenteration before and after implementation of an enhanced recovery after surgery program. Gynecol Oncol. (2024) 189:80–7. doi: 10.1016/j.ygyno.2024.07.674, [DOI] [PubMed] [Google Scholar]
  • 31.Matsui R, Sagawa M, Inaki N, Fukunaga T, Nunobe S. Impact of perioperative immunonutrition on postoperative outcomes in patients with upper gastrointestinal cancer: a systematic review and meta-analysis of randomized controlled trials. Nutrients. (2024) 16:577. doi: 10.3390/nu16050577, [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Pu H, Heighes PT, Simpson F, Wang Y, Liang Z, Wischmeyer P, et al. Early oral protein-containing diets following elective lower gastrointestinal tract surgery in adults: a meta-analysis of randomized clinical trials. Perioper Med. (2021) 10:10. doi: 10.1186/s13741-021-00179-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Canzan F, Longhini J, Caliaro A, Cavada ML, Mezzalira E, Paiella S, et al. The effect of early oral postoperative feeding on the recovery of intestinal motility after gastrointestinal surgery: a systematic review and meta-analysis of randomized clinical trials. Front Nutr. (2024) 11:1369141. doi: 10.3389/fnut.2024.1369141, [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Hogan S, Reece L, Solomon M, Rangan A, Carey S. Early enteral feeding is beneficial for patients after pelvic exenteration surgery: a randomized controlled trial. JPEN J Parenter Enteral Nutr. (2022) 46:411–21. doi: 10.1002/jpen.2120, [DOI] [PubMed] [Google Scholar]
  • 35.Capitao C, Coutinho D, Neves PM, Capelas ML, Pimenta NM, Santos T, et al. Protein intake and muscle mass maintenance in patients with cancer types with high prevalence of sarcopenia: a systematic review. Support Care Cancer. (2022) 30:3007–15. doi: 10.1007/s00520-021-06633-8, [DOI] [PubMed] [Google Scholar]
  • 36.Cardoso MM, Baixinho CL, Silva GTR, Ferreira O. Nursing interventions in the perioperative pathway of the patient with breast cancer: a scoping review. Healthcare. (2023) 11:1717. doi: 10.3390/healthcare11121717, [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Wang D, Hu Y, Liu K, Liu Z, Chen X, Cao L, et al. Issues in patients' experiences of enhanced recovery after surgery: a systematic review of qualitative evidence. BMJ Open. (2023) 13:e068910. doi: 10.1136/bmjopen-2022-068910 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Ang KYH, Stringer G, Collins J, Barker LA. Patient experiences of nutrition in enhanced recovery after colorectal surgery: a systematic review. Nutrients. (2026) 18:1790. doi: 10.3390/nu18111790, [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Jacobson R, Gurd EN, Pimiento JM. Long-term nutrition alterations after surgery for gastrointestinal cancers. Nutr Clin Pract. (2023) 38:721–30. doi: 10.1002/ncp.11035, [DOI] [PubMed] [Google Scholar]
  • 40.Yan H, He F, Wei J, Zhang Q, Guo C, Ni J, et al. Effects of individualized dietary counseling on nutritional status and quality of life in post-discharge patients after surgery for gastric cancer: a randomized clinical trial. Front Oncol. (2023) 13:1058187. doi: 10.3389/fonc.2023.1058187, [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.AlAshqar A, Ghazarian M, Webster EM, Upadhyay A, Azodi M, Schwartz PE, et al. Surgical and oncologic outcomes in surgically treated women 80 years and older with endometrioid endometrial cancer as a function of their comorbidities. Gynecol Oncol Rep. (2023) 49:101240. doi: 10.1016/j.gore.2023.101240, [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Pandraklakis A, Haidopoulos D, Lappas T, Stamatakis E, Oikonomou MD, Valsamidis D, et al. Enhanced recovery after surgery protocols in obese gynecological oncology patients: a single-center experience. Cureus. (2023) 15:e40453. doi: 10.7759/cureus.40453, [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Frontiers in Public Health are provided here courtesy of Frontiers Media SA

RESOURCES